Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry (Q39870160)

15 September 2017

title

Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry (English)

1 reference

15 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

G Rastrelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

L Giovannini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A E Calogero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

D Gianfrilli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

E Serra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A Pizzocaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

V A Giagulli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

G Vancieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

A Sperandio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

S Andò

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

R Selice

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

G Luca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

F Cocchiara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

D Canale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

M Maggi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

1 April 2016

1 reference

Journal of Endocrinological Investigation

15 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

695-708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Androgen regulation of prostate cancer: Where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

How to define hypogonadism? Results from a population of men consulting for sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

How to recognize late-onset hypogonadism in men with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Benign prostatic hyperplasia: a new metabolic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Relationship between lower urinary tract symptoms and metabolic syndrome in a Chinese male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Toll-like receptor 4 in rat prostate: modulation by testosterone and acute bacterial infection in epithelial and stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone regulates tight junction proteins and influences prostatic autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone Replacement Effectively Inhibits the Development of Experimental Autoimmune Orchitis in Rats: Evidence for a Direct Role of Testosterone on Regulatory T Cell Expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone supplementation and sexual function: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Sildenafil increases serum testosterone levels by a direct action on the testes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

The management of erectile dysfunction with placebo only: does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Testosterone and metabolic syndrome: a meta-analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-016-0461-5

Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study

21 January 2018

1 reference

12 December 2020

American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

1 reference

12 December 2020

Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells.

1 reference

12 December 2020

Circulating free testosterone in obese men after bariatric surgery increases in parallel with insulin sensitivity.

1 reference

12 December 2020

Vitamin D levels and bone mineral density: are LH levels involved in the pathogenesis of bone impairment in hypogonadal men?

1 reference

12 December 2020

Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction

1 reference

12 December 2020

Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases

1 reference

12 December 2020

Perspective: Regulatory Agencies' Changes to Testosterone Product Labeling

1 reference

12 December 2020

THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study

1 reference

12 December 2020

Testosterone and cardiovascular risk in patients with erectile dysfunction

1 reference

12 December 2020

A critical evaluation of simple methods for the estimation of free testosterone in serum

1 reference

12 December 2020

Hypogonadism and metabolic syndrome

1 reference

12 December 2020

Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study

1 reference

12 December 2020

The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume

1 reference

12 December 2020

Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score

1 reference

12 December 2020

10.1007/S40618-016-0461-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27037688%20AND%20SRC:MED&resulttype=core&format=json